- Home
- DCBO vs TLRY Comparison
DCBO vs TLRY Comparison
Compare DCBO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCBO
- TLRY
- Stock Information
- Founded
- DCBO 2016
- TLRY N/A
- Country
- DCBO Canada
- TLRY Canada
- Employees
- DCBO N/A
- TLRY N/A
- Industry
- DCBO
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- DCBO
- TLRY Health Care
- Exchange
- DCBO Nasdaq
- TLRY Nasdaq
- Market Cap
- DCBO 1.3B
- TLRY 1.3B
- IPO Year
- DCBO 2020
- TLRY 2018
- Fundamental
- Price
- DCBO $42.14
- TLRY $1.20
- Analyst Decision
- DCBO Strong Buy
- TLRY Hold
- Analyst Count
- DCBO 7
- TLRY 3
- Target Price
- DCBO $54.71
- TLRY $1.88
- AVG Volume (30 Days)
- DCBO 59.2K
- TLRY 43.8M
- Earning Date
- DCBO 02-21-2025
- TLRY 01-10-2025
- Dividend Yield
- DCBO N/A
- TLRY N/A
- EPS Growth
- DCBO 1403.35
- TLRY N/A
- EPS
- DCBO 0.56
- TLRY N/A
- Revenue
- DCBO $209,170,000.00
- TLRY $829,216,000.00
- Revenue This Year
- DCBO $21.91
- TLRY $16.98
- Revenue Next Year
- DCBO $14.25
- TLRY $5.96
- P/E Ratio
- DCBO $70.73
- TLRY N/A
- Revenue Growth
- DCBO 22.67
- TLRY 18.38
- 52 Week Low
- DCBO $33.81
- TLRY $1.14
- 52 Week High
- DCBO $56.41
- TLRY $2.97
- Technical
- Relative Strength Index (RSI)
- DCBO 31.21
- TLRY 40.97
- Support Level
- DCBO $41.50
- TLRY $1.15
- Resistance Level
- DCBO $43.19
- TLRY $1.23
- Average True Range (ATR)
- DCBO 1.12
- TLRY 0.08
- MACD
- DCBO -0.16
- TLRY -0.02
- Stochastic Oscillator
- DCBO 13.06
- TLRY 13.51
About DCBO Docebo Inc.
Docebo Inc is a provider of cloud-based learning management systems.. The solutions provided by the company are sold on a subscription model and subscriptions are typically structured with an initial fixed term of between one and three years, without the ability for customers to terminate for convenience. The company charges its customers based on a per-learner, per-module basis, varying depending on the size of the organization and complexity. The majority of the revenue is derived from customers based in North America.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.